Grow Pharma · Sativa-dominant Hybrid

Grow Pharma T20 Blue Dream

Bred by Grow Pharma.

THC18–22% THCCultivationIndoor
Grow Pharma T20 Blue Dream — botanical reference image
Educational reference. Not medical advice. Medical cannabis is a prescription-only medicine in the UK — consult a specialist clinician.

History & Producer

Origin

Classic Blue Dream balanced for daytime relief.

Genetics

Lineage

Blueberry × Haze

Indica 40%Sativa 60%

Cannabinoid & Production Profile

Specifications

THC
18–22% THC
CBD
<1.0%
Classification
Sativa-dominant Hybrid
Cultivation
Indoor
Irradiation
Beta (e-beam)

Dominant Terpenes

Aromatic Compounds

  • β-Caryophyllene0.46%
  • Limonene0.34%
  • Myrcene0.31%

Sensory Profile

Appearance, Flavour & Aroma

Appearance

Light blue-green buds with deep orange pistils.

Flavour

Sweet berry, herbal haze.

Aroma

Blueberry, haze.

Reported Effects

Effect Profile

Aggregated from patient diaries and prescriber feedback. Intensity is relative within this strain's profile, not an absolute clinical measure.

Relaxed76%
Euphoric72%
Uplifted66%
Focused58%
Pain Relief70%
Calm74%

Condition Recommendations

Discussed Indications

  • Chronic pain

    Evidence · Emerging

    Balanced profile often used across daytime and evening dosing.

    Strong fit
  • Anxiety

    Evidence · Limited

    Caryophyllene and linalool may support calming effects.

    Moderate fit
  • Appetite loss

    Evidence · Limited

    THC component commonly discussed for appetite support.

    Moderate fit
  • PTSD-related symptoms

    Evidence · Anecdotal

    Patient reports suggest improved sleep continuity; evidence base small.

    Moderate fit

Not a substitute for a prescriber's assessment. Suitability depends on tolerance, comorbidities and concomitant medication.